Petals and Thorns in Programmed Death-Ligand 1 Testing: Is All Non-Small Cell Lung Cancer Diagnostic Material Suitable?
2018-01-01 Bravaccini, S; Bronte, G
Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy
2015-01-01 Rocca, A; Andreis, D; Fedeli, A; Maltoni, R; Sarti, S; Cecconetto, L; Pietri, E; Schirone, A; Bravaccini, S; Serra, P; Farolfi, A; Amadori, D
Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer
2019-01-01 Pietri, E; Massa, I; Bravaccini, S; Ravaioli, S; Tumedei, Mm; Petracci, E; Donati, C; Schirone, A; Piacentini, F; Gianni, L; Nicolini, M; Campadelli, E; Gennari, A; Saba, A; Campi, B; Valmorri, L; Andreis, D; Fabbri, F; Amadori, D; Rocca, A
Potential of telomerase expression and activity in cervical specimens as a diagnostic tool
2005-01-01 Bravaccini, S; Sanchini, Ma; Amadori, A; Medri, L; Saragoni, L; Calistri, D; Monti, F; Volpi, A; Amadori, D
Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study
2012-01-01 Ulivi, P; Capelli, L; Valgiusti, M; Zoli, W; Scarpi, E; Chiadini, E; Rosetti, P; Bravaccini, S; Calistri, D; Saragoni, L; Gardini, Ac; Ragazzini, A; Frassineti, Gl; Amadori, D; Passardi, A
Predictive role of telomerase activity in the clinical outcome of patients with benign lesions of the uterine cervix or CIN
2012-01-01 Bravaccini, S; Amadori, A; Scarpi, E; Tumedei, Mm; Zoli, W; Silvestrini, R
Primary epithelioid angiosarcoma of the thyroid: A case report
2021-01-01 Bravaccini, S; Caprara, L; Cortecchia, S; De Lillo, M; Lega, S; Poli, F; Tasca, I; Vacirca, A; Cimatti, Mc; Tumedei, Mm; Ravaioli, S; Puccetti, M
Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells
2005-01-01 Fabbri, F; Brigliadori, G; Ulivi, P; Tesei, A; Vannini, I; Rosetti, M; Bravaccini, S; Amadori, D; Bolla, M; Zoli, W
Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer
2019-01-01 D'Arcangelo, M; D'Incecco, A; Ligorio, C; Damiani, S; Puccetti, M; Bravaccini, S; Terracciano, L; Bennati, C; Minuti, G; Vecchiarelli, S; Landi, L; Milesi, M; Meroni, A; Ravaioli, S; Tumedei, Mm; Incarbone, M; Cappuzzo, F.
Progress with palbociclib in breast cancer: latest evidence and clinical considerations
2017-01-01 Rocca, A; Schirone, A; Maltoni, R; Bravaccini, S; Cecconetto, L; Farolfi, A; Bronte, G; Andreis, D
Proposed clinical phases for the improvement of personalized treatment of checkpoint inhibitor-related pneumonitis
2022-01-01 Zhou, C; Yang, Y; Lin, X; Fang, N; Chen, L; Jiang, J; Deng, H; Deng, Y; Wan, M; Qiu, G; Sun, N; Wu, D; Long, X; Zhong, C; Xie, X; Xie, Z; Liu, M; Ouyang, M; Qin, Y; Petrella, F; Fiorelli, A; Bravaccini, S; Kataoka, Y; Watanabe, S; Goto, T; Solli, P; Igai, H; Saito, Y; Tsoukalas, N; Nakada, T; Li, S; Chen, R
Relevance of urine telomerase in the diagnosis of bladder cancer
2005-01-01 Sanchini, Ma; Gunelli, R; Nanni, O; Bravaccini, S; Fabbri, C; Sermasi, A; Bercovich, E; Ravaioli, A; Amadori, D; Calistri, D
Role of androgen and estrogen receptors as prognostic and potential predictive markers of ductal carcinoma in situ of the breast
2015-01-01 Tumedei, Mm; Silvestrini, R; Ravaioli, S; Massa, I; Maltoni, R; Rocca, A; Folli, S; Buggi, F; Curcio, A; Serra, L; Puccetti, M; Amadori, D; Bravaccini, S
Role of Telomerase in Cervical Lesions as Prognostic Marker: A Comparison Between Immunohistochemistry and Fluorescence In Situ Hybridization
2017-01-01 Ravaioli, S; Tumedei, Mm; Amadori, A; Puccetti, M; Chiadini, E; Bravaccini, S
Sacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer
2022-01-01 Maltoni, R; Bravaccini, S
Safety and efficacy of anti-PD-1 inhibitors in Chinese patients with advanced lung cancer and hepatitis B virus infection: a retrospective single-center study
2021-01-01 Xu, F; Zeng, Z; Yan, B; Fu, Yq; Sun, Yl; Yang, Gd; Tu, Lf; Watanabe, S; Jabbour, Sk; Bravaccini, S; Fanini, F; Zhou, Jy; Shen, Yh
Setting up a community-based cervical screening service in a low-income country: a pilot study from north-western Tanzania
2017-01-01 Masalu, N; Serra, P; Amadori, D; Kahima, J; Majinge, C; Rwehabura, J; Nanni, O; Bravaccini, S; Puccetti, M; Tumino, R; Bucchi, L
Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy
2019-01-01 Hong, Sp; Chan, Te; Lombardo, Y; Corleone, G; Rotmensz, N; Bravaccini, S; Rocca, A; Pruneri, G; Mcewen, Kr; Coombes, Rc; Barozzi, I; Magna, L
Sorafenib for the treatment of breast cancer
2017-01-01 Bronte, G; Andreis, D; Bravaccini, S; Maltoni, R; Cecconetto, L; Schirone, A; Farolfi, A; Fedeli, A; Serra, P; Donati, C; Amadori, D; Rocca, A
Robotic versus open total mesorectal excision for rectal cancer: Comparative study of short and long-term outcomes
2014-01-01 Ghezzi, T. L.; Luca, F.; Valvo, M.; Corleta, O. C.; Zuccaro, M.; Cenciarelli, S.; Biffi, R.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Petals and Thorns in Programmed Death-Ligand 1 Testing: Is All Non-Small Cell Lung Cancer Diagnostic Material Suitable? | 1-gen-2018 | Bravaccini, S; Bronte, G | |
| Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy | 1-gen-2015 | Rocca, A; Andreis, D; Fedeli, A; Maltoni, R; Sarti, S; Cecconetto, L; Pietri, E; Schirone, A; Bravaccini, S; Serra, P; Farolfi, A; Amadori, D | |
| Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer | 1-gen-2019 | Pietri, E; Massa, I; Bravaccini, S; Ravaioli, S; Tumedei, Mm; Petracci, E; Donati, C; Schirone, A; Piacentini, F; Gianni, L; Nicolini, M; Campadelli, E; Gennari, A; Saba, A; Campi, B; Valmorri, L; Andreis, D; Fabbri, F; Amadori, D; Rocca, A | |
| Potential of telomerase expression and activity in cervical specimens as a diagnostic tool | 1-gen-2005 | Bravaccini, S; Sanchini, Ma; Amadori, A; Medri, L; Saragoni, L; Calistri, D; Monti, F; Volpi, A; Amadori, D | |
| Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study | 1-gen-2012 | Ulivi, P; Capelli, L; Valgiusti, M; Zoli, W; Scarpi, E; Chiadini, E; Rosetti, P; Bravaccini, S; Calistri, D; Saragoni, L; Gardini, Ac; Ragazzini, A; Frassineti, Gl; Amadori, D; Passardi, A | |
| Predictive role of telomerase activity in the clinical outcome of patients with benign lesions of the uterine cervix or CIN | 1-gen-2012 | Bravaccini, S; Amadori, A; Scarpi, E; Tumedei, Mm; Zoli, W; Silvestrini, R | |
| Primary epithelioid angiosarcoma of the thyroid: A case report | 1-gen-2021 | Bravaccini, S; Caprara, L; Cortecchia, S; De Lillo, M; Lega, S; Poli, F; Tasca, I; Vacirca, A; Cimatti, Mc; Tumedei, Mm; Ravaioli, S; Puccetti, M | |
| Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells | 1-gen-2005 | Fabbri, F; Brigliadori, G; Ulivi, P; Tesei, A; Vannini, I; Rosetti, M; Bravaccini, S; Amadori, D; Bolla, M; Zoli, W | |
| Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer | 1-gen-2019 | D'Arcangelo, M; D'Incecco, A; Ligorio, C; Damiani, S; Puccetti, M; Bravaccini, S; Terracciano, L; Bennati, C; Minuti, G; Vecchiarelli, S; Landi, L; Milesi, M; Meroni, A; Ravaioli, S; Tumedei, Mm; Incarbone, M; Cappuzzo, F. | |
| Progress with palbociclib in breast cancer: latest evidence and clinical considerations | 1-gen-2017 | Rocca, A; Schirone, A; Maltoni, R; Bravaccini, S; Cecconetto, L; Farolfi, A; Bronte, G; Andreis, D | |
| Proposed clinical phases for the improvement of personalized treatment of checkpoint inhibitor-related pneumonitis | 1-gen-2022 | Zhou, C; Yang, Y; Lin, X; Fang, N; Chen, L; Jiang, J; Deng, H; Deng, Y; Wan, M; Qiu, G; Sun, N; Wu, D; Long, X; Zhong, C; Xie, X; Xie, Z; Liu, M; Ouyang, M; Qin, Y; Petrella, F; Fiorelli, A; Bravaccini, S; Kataoka, Y; Watanabe, S; Goto, T; Solli, P; Igai, H; Saito, Y; Tsoukalas, N; Nakada, T; Li, S; Chen, R | |
| Relevance of urine telomerase in the diagnosis of bladder cancer | 1-gen-2005 | Sanchini, Ma; Gunelli, R; Nanni, O; Bravaccini, S; Fabbri, C; Sermasi, A; Bercovich, E; Ravaioli, A; Amadori, D; Calistri, D | |
| Role of androgen and estrogen receptors as prognostic and potential predictive markers of ductal carcinoma in situ of the breast | 1-gen-2015 | Tumedei, Mm; Silvestrini, R; Ravaioli, S; Massa, I; Maltoni, R; Rocca, A; Folli, S; Buggi, F; Curcio, A; Serra, L; Puccetti, M; Amadori, D; Bravaccini, S | |
| Role of Telomerase in Cervical Lesions as Prognostic Marker: A Comparison Between Immunohistochemistry and Fluorescence In Situ Hybridization | 1-gen-2017 | Ravaioli, S; Tumedei, Mm; Amadori, A; Puccetti, M; Chiadini, E; Bravaccini, S | |
| Sacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer | 1-gen-2022 | Maltoni, R; Bravaccini, S | |
| Safety and efficacy of anti-PD-1 inhibitors in Chinese patients with advanced lung cancer and hepatitis B virus infection: a retrospective single-center study | 1-gen-2021 | Xu, F; Zeng, Z; Yan, B; Fu, Yq; Sun, Yl; Yang, Gd; Tu, Lf; Watanabe, S; Jabbour, Sk; Bravaccini, S; Fanini, F; Zhou, Jy; Shen, Yh | |
| Setting up a community-based cervical screening service in a low-income country: a pilot study from north-western Tanzania | 1-gen-2017 | Masalu, N; Serra, P; Amadori, D; Kahima, J; Majinge, C; Rwehabura, J; Nanni, O; Bravaccini, S; Puccetti, M; Tumino, R; Bucchi, L | |
| Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy | 1-gen-2019 | Hong, Sp; Chan, Te; Lombardo, Y; Corleone, G; Rotmensz, N; Bravaccini, S; Rocca, A; Pruneri, G; Mcewen, Kr; Coombes, Rc; Barozzi, I; Magna, L | |
| Sorafenib for the treatment of breast cancer | 1-gen-2017 | Bronte, G; Andreis, D; Bravaccini, S; Maltoni, R; Cecconetto, L; Schirone, A; Farolfi, A; Fedeli, A; Serra, P; Donati, C; Amadori, D; Rocca, A | |
| Robotic versus open total mesorectal excision for rectal cancer: Comparative study of short and long-term outcomes | 1-gen-2014 | Ghezzi, T. L.; Luca, F.; Valvo, M.; Corleta, O. C.; Zuccaro, M.; Cenciarelli, S.; Biffi, R. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista15368
- 4 Contributo in Atti di Convegno ...2
- 2 Contributo in Volume1
Data di pubblicazione
- In corso di stampa17
- 2020 - 20267039
- 2010 - 20195807
- 2000 - 20091967
- 1990 - 1999480
- 1980 - 198960
- 1979 - 19791
Editore
- Trans Tech Publications1
Rivista
- INTERNATIONAL JOURNAL OF MOLECULA...225
- JOURNAL OF CLINICAL MEDICINE153
- CANCERS122
- INTERNATIONAL JOURNAL OF ENVIRONM...110
- LNS. ACTIVITY REPORT85
- PHD KORE REVIEW78
- DIAGNOSTICS77
- RIVISTA DELLA COOPERAZIONE GIURID...76
- SCIENTIFIC REPORTS73
- SUSTAINABILITY72
Serie
- ADVANCED MATERIALS RESEARCH1
- WORKING PAPERS RES1
Keyword
- COVID-19257
- Humans250
- Female133
- Male127
- SARS-CoV-2108
- inflammation103
- oxidative stress85
- Italy78
- Adult69
- Middle Aged67
Lingua
- eng10819
- ita2587
- fre66
- spa64
- lat12
- ger11
- por6
- ara3
- cat3
- enm2
Accesso al fulltext
- no fulltext15371